Pin Therapeutics is a pharmaceutical startup focusing on advanced protein degradation therapeutics.
Pin Therapeutics has raised $13.6M in total funding. The most recent round was Series C. The last funding was announced in December 2024.
Pin Therapeutics's investors include KOREA INVESTMENT & SECURITIES, Korea Investment Partners, Daewoong Pharmaceutical, Yuanta Investment, Korea Development Bank.
Pin Therapeutics is headquartered in Seongnam, South Korea.
Pin Therapeutics is a pharmaceutical startup focusing on advanced protein degradation therapeutics.
Pin Therapeutics is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Pin Therapeutics — Funding & Investors." VCBacked, December 27, 2024, https://www.vcbacked.co/company/pin-therapeutics. Accessed September 14, 2026.
VCBacked. (2024). Pin Therapeutics — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/pin-therapeutics
{{cite web |title=Pin Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/pin-therapeutics |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated